Abiopharma

Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action

New Form SCHEDULE 13G/A - SOLENO THERAPEUTICS INC Filed: 2025-05-14 AccNo: 0001274173-25-000135 Size: 9 KB

New Form SCHEDULE 13G/A - 89bio, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000130 Size: 10 KB

New Form SCHEDULE 13G/A - Lexeo Therapeutics, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000131 Size: 10 KB

New Form SCHEDULE 13G/A - AVADEL PHARMACEUTICALS PLC Filed: 2025-05-14 AccNo: 0001274173-25-000129 Size: 10 KB

New Form SCHEDULE 13G/A - Mirum Pharmaceuticals, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000128 Size: 10 KB

Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference

New Form SCHEDULE 13G/A - Monopar Therapeutics Filed: 2025-05-14 AccNo: 0001274173-25-000127 Size: 10 KB

New Form SCHEDULE 13G/A - Ascendis Pharma A/S Filed: 2025-05-14 AccNo: 0001274173-25-000126 Size: 9 KB

New Form SCHEDULE 13G - Travere Therapeutics, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000125 Size: 9 KB

New Form SCHEDULE 13G - Tyra Biosciences, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000122 Size: 9 KB

New Form SCHEDULE 13G - Verona Pharma plc Filed: 2025-05-14 AccNo: 0001274173-25-000120 Size: 9 KB

New Form SCHEDULE 13G - Praxis Precision Medicines, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000119 Size: 9 KB

NRC Health & TGI | Shaping the Future of Healthcare Together in Orlando

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3